Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia

@article{Gentile2000ComparativeES,
  title={Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia},
  author={S. Gentile and S. Turco and G. Guarino and C. F. Sasso and M. Amodio and P. Magliano and T. Salvatore and G. Corigliano and M. Agrusta and G. de Simone and I. Gaeta and B. Oliviero and R. Torella},
  journal={Diabetes},
  year={2000},
  volume={2}
}
  • S. Gentile, S. Turco, +10 authors R. Torella
  • Published 2000
  • Medicine
  • Diabetes
    • Although there is little information from primary or secondary prevention trials on cholesterol‐lowering medication in diabetic patients, the reduction of elevated cholesterol is widely recommended for this group. The American Diabetes Association (ADA) recommends drug therapy in diabetic patients if low density lipoprotein (LDL)‐cholesterol remains at > 130 mg/dl, or > 100 mg/dl in patients with macroangiopathy, after dietary intervention. When cholesterol‐lowering medication is indicated, the… CONTINUE READING
    View on Wiley
    ncbi.nlm.nih.gov
    52 Citations
    Highly Influencial Citations
    1
    Background Citations
    13
    Methods Citations
    2
    Results Citations
    3
    52 Citations
    Citation Type

    Citation Type

    Comparative efficacy and safety of atorvastatin, simvastatin and lovastatin in the management of dyslipidemic Type 2 diabetic patients
    • 4
    Comparative efficacy and safety of atorvastatin, simvastatin and lovastatin in the management of dyslipidemic Type 2 diabetic patients
    Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics
    • 120
    Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.
    • 79
    Atorvastatin
    Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.
    • 124
    Switching From Atorvastatin to Simvastatin in Patients at High Cardiovascular Risk: Effects on Low-Density Lipoprotein Cholesterol
    • 27
    Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control.
    • F. Hobbs
    • Medicine
    • International journal of cardiology
    • 2006
    • 22
    A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin.
    • 41
    Combined Analysis of Pharmacokinetic and Efficacy Data of Preclinical Studies with Statins Markedly Improves Translation of Drug Efficacy to Human Trials
    • 22
    • PDF

    References

    SHOWING 1-10 OF 64 REFERENCES
    Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia.
    • 131
    Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
    • 234
    Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
    • 822
    A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia
    • 164
    A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia.
    • 71
    Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.
    • 436
    Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
    • 3,823
    • PDF
    Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin.
    • C. Dujovne, A N Chremos, +7 authors D. Nash
    • Medicine
    • The American journal of medicine
    • 1991
    • 107
    Gemfibrozil Alone and in Combination With Lovastatin for Treatment of Hypertriglyceridemia in NIDDM
    • 100
    Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus.
    • 164